WT1 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: In addition, blood examination revealed a positive expression for WT1 mRNA before imatinib therapy which turned negative after remission, suggesting that WT1 mRNA level is a possible marker that could distinguish CEL from HES.